Viking Therapeutics (VKTX) Current Assets (2016 - 2025)
Historic Current Assets for Viking Therapeutics (VKTX) over the last 12 years, with Q4 2025 value amounting to $715.6 million.
- Viking Therapeutics' Current Assets fell 2112.15% to $715.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $715.6 million, marking a year-over-year decrease of 2112.15%. This contributed to the annual value of $715.6 million for FY2025, which is 2112.15% down from last year.
- As of Q4 2025, Viking Therapeutics' Current Assets stood at $715.6 million, which was down 2112.15% from $738.7 million recorded in Q3 2025.
- Viking Therapeutics' Current Assets' 5-year high stood at $966.3 million during Q1 2024, with a 5-year trough of $149.5 million in Q1 2023.
- In the last 5 years, Viking Therapeutics' Current Assets had a median value of $374.3 million in 2023 and averaged $491.4 million.
- In the last 5 years, Viking Therapeutics' Current Assets plummeted by 2636.78% in 2022 and then skyrocketed by 54651.63% in 2024.
- Quarter analysis of 5 years shows Viking Therapeutics' Current Assets stood at $210.5 million in 2021, then fell by 20.66% to $167.0 million in 2022, then surged by 119.84% to $367.2 million in 2023, then surged by 147.05% to $907.2 million in 2024, then dropped by 21.12% to $715.6 million in 2025.
- Its last three reported values are $715.6 million in Q4 2025, $738.7 million for Q3 2025, and $827.0 million during Q2 2025.